NVO
Novo Nordisk A/S
NVO has lower modeled downside risk, despite its lower overall score.
PANW
Palo Alto Networks, Inc.
PANW has a slight edge over NVO overall on the model score.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PANW Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Strong | |
| Strong |
PANW's revenue, cash flow and balance sheet are currently strong, and its profitability is stable.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO has the edge over PANW in the historical PE scenario, which offers more potential upside but is not a forecast.
PANW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 48x | $19.37 | -94% |
| Forward | 74x | $323 | — |
| Fair | 117x | $46.90 | -85% |
| Expensive | 344x | $138 | -57% |
| Current | 807x | $323 | — |
Historical ranges are pointers, not guarantees.
PANW's PE is in its expensive range at 807x. If earnings grow as analysts expect, today's price would be 74x next year's earnings, in its cheap range.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
PANW Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Strong growth | |
| Weakening | |
| Moderate | |
| High |
PANW has the edge over NVO on the outlook, with more favorable earnings expectations.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over PANW on earnings, with more consistent year-over-year improvement.
PANW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.34 | +985% |
| Q3 2026 | $0.40 | -75% |
| Q2 2026 | $1.21 | -32% |
| Q1 2026 | $1.80 | +0.6% |
| Q4 2025 | $1.57 | -59% |
| Q3 2025 | $1.60 | -56% |
| Q2 2025 | $1.77 | -49% |
| Q1 2025 | $1.79 | -44% |
| Q4 2024 | $3.85 | +333% |
PANW's earnings per share have fallen from their peak: $0.40 over the past year, against $3.85 in late 2024.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over PANW on profitability, with a higher operating margin.
PANW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.4B | +34% |
| Q2 2026 | $3B | +31% |
| Q1 2026 | $2.6B | +15% |
| Q4 2025 | $2.5B | +16% |
| Q3 2025 | $2.5B | +16% |
| Q2 2025 | $2.3B | +15% |
| Q1 2025 | $2.3B | +14% |
| Q4 2024 | $2.1B | +14% |
PANW's revenue has grown year over year every quarter since late 2020: $3.4B last quarter, up 34% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5% | -15 points |
| Q2 2026 | -6.1% | -16 points |
| Q1 2026 | 15% | +4.7 points |
| Q4 2025 | 12% | -0.9 points |
| Q3 2025 | 20% | +8.7 points |
| Q2 2025 | 9.6% | +0.7 points |
| Q1 2025 | 11% | +7.9 points |
| Q4 2024 | 13% | +1.9 points |
PANW's operating margin was 5% last quarter, down 15 points from the same quarter a year ago.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO still generates free cash flow, though less than at its 2026 peak: $7.3B over the past year.
PANW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +34% |
| Q2 2026 | $788M | +41% |
| Q1 2026 | $384M | -25% |
| Q4 2025 | $1.7B | +15% |
| Q3 2025 | $934.5M | +101% |
| Q2 2025 | $560.4M | +14% |
| Q1 2025 | $509.4M | -22% |
| Q4 2024 | $1.5B | -1.6% |
PANW's free cash flow has been positive every quarter for seven years: $4.1B over the past year, up 19% from the year before.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over PANW on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
PANW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.6% | -37M shares |
| 1 year | +7.7% | +54.7M shares |
| 3 years | +12% | +79.4M shares |
| 5 years | +32% | +186M shares |
| Available history | +32% | +184M shares |
PANW has 764M diluted shares, up 7.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $500M |
| Q1 2024 | — |
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
PANW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.6x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -2.3x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -2.2x | Net Cash |
PANW has the edge over NVO on leverage, with a lower net debt burden relative to earnings.
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
PANW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.6 | Neutral |
| Stochastic | 18.8 | Oversold |
PANW's weekly RSI is 50 (neutral) and its Stochastic is 19 (oversold).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO has the edge over PANW on valuation relative to its sector.
PANW PE vs Technology Sector
| Metric | PANW | Sector median | Relative |
|---|---|---|---|
| PE | 807x | 28x | 2,795% above |
| PE % | 89 | 35 | 54 pts above |
PANW is trading at 807x earnings, a 2795% premium to the Technology sector's median of 28x.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
PANW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $365.2 | 12% below |
| 20 week MA | $355.8 | 9.3% below |
| 50 week MA | $260.9 | 24% above |
| 100 week MA | $225.6 | 43% above |
| 200 week MA | $182.3 | 77% above |
PANW has the edge over NVO on trend strength, trading above more of its moving averages.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has finished higher in four of the last six years, two of them by more than 50%. It's down 22% so far in 2026.
PANW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $38.9 | $61.2 | +57% |
| 2021 | $61.2 | $93.6 | +53% |
| 2022 | $93.6 | $70.6 | -25% |
| 2023 | $70.6 | $147.4 | +109% |
| 2024 | $147.4 | $186.2 | +26% |
| 2025 | $186.2 | $188.5 | +1.2% |
| 2026 YTD | $188.5 | $322.7 | +71% |
PANW has the edge over NVO on returns for 2026, with the stronger performance.